- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Paclitaxel
Total 4005 results
-
Atlantic Health SystemCornerstone PharmaceuticalsUnknownPancreatic Cancer | Metastatic Pancreatic CancerUnited States
-
Chinese PLA General HospitalUnknownAdvanced Pancreatic CancerChina
-
Gesellschaft fur Medizinische Innovation - Hamatologie...iOMEDICO AGCompletedMetastatic Breast CancerGermany
-
Hoffmann-La RocheCompletedBreast CancerItaly, Spain, China, Taiwan, Russian Federation, Canada, Germany, Austria, Hungary, Belgium, Australia, Brazil, Mexico, Poland, Panama
-
Beijing Tongren HospitalRecruitingHead and Neck Squamous Cell Carcinoma | Neoadjuvant Therapy | PembrolizumabChina
-
Institut Paoli-CalmettesMSD France; OncodistinctRecruitingInflammatory Breast CancerFrance, Belgium
-
SynerGene Therapeutics, Inc.RecruitingMetastatic Pancreatic CancerUnited States
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited Kingdom, United States, Israel, Spain, Italy, Czechia, Canada, Hungary, Poland, Russian Federation, Brazil, Ukraine
-
University Hospital OstravaCompleted
-
Washington University School of MedicineCompletedPancreatic CancerUnited States
-
Peking UniversityTerminated
-
Actuate Therapeutics Inc.Active, not recruitingSarcoma | Cancer | Breast Neoplasms | Neoplasm Metastasis | Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Bone Cancer | Malignant Glioma | Bone Metastases | Pancreas Cancer | Renal Cancer | Refractory Non-Hodgkin Lymphoma | Bone Neoplasm | Neoplasm, Breast | Refractory Cancer | Refractory Neoplasm | Resistant... and other conditionsUnited States, Belgium, Canada, Spain, France, Netherlands, Portugal
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of ChicagoCompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Mohammed Najeeb Al HallakNational Cancer Institute (NCI)CompletedAcinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Stage IV Pancreatic CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); NovartisWithdrawnUnspecified Adult Solid Tumor, Protocol Specific | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
Yonsei UniversityNot yet recruitingRecurrent/Metastatic Gastric CancerKorea, Republic of
-
Sun Yat-sen UniversityActive, not recruitingNasopharyngeal CancerChina
-
Yonsei UniversityActive, not recruiting
-
Institut Paoli-CalmettesTerminated
-
University of ZurichCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
National University Hospital, SingaporeUnknown
-
Peking UniversityUnknown
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedBreast CancerCanada, United States
-
Chang Gung Memorial HospitalSinphar Pharmaceutical Co., LtdUnknown
-
National Cancer Institute (NCI)Completed
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., LtdRecruitingTriple Negative Breast Cancer (TNBC)China
-
Tianjin Medical University Second HospitalRecruitingMuscle Invasive Bladder Cancer Urothelial CarcinomaChina
-
Adlai Nortye Biopharma Co., Ltd.Active, not recruitingHead and Neck CancerUnited States, United Kingdom, France, Hungary, Spain, Japan, Italy, Hong Kong, Taiwan, Korea, Republic of, Germany, Australia, China, Canada, Belgium, Argentina, Poland
-
Spanish Breast Cancer Research GroupCelgeneCompleted
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyWithdrawnEsophageal Squamous Cell Carcinoma
-
Translational Research in OncologyStand Up To Cancer; Effector TherapeuticsCompleted
-
UNC Lineberger Comprehensive Cancer CenterCelgeneCompletedNon Small Cell Lung Cancer (NSCLC)United States
-
AnewPharmaUnknownAdvanced Gastric CancerChina
-
Icahn School of Medicine at Mount SinaiCelgene CorporationTerminated
-
Hellenic Oncology Research GroupCompletedStomach and Gastro-Esophageal Junction (GEJ) CancerGreece
-
Osaka Medical CollegeCompletedBreast Cancer | Effects of Chemotherapy | HER-2 Positive Breast CancerJapan
-
Children's Hospital of PhiladelphiaTerminatedBrain and Central Nervous System TumorsUnited States
-
Second Hospital of Jilin UniversityUnknownPercutaneous Coronary Intervention | AngioplastyChina
-
Johnson & Johnson Pharmaceutical Research & Development...ALZA; Sequus PharmaceuticalsTerminated
-
Achieve Life SciencesCompletedBreast CancerRussian Federation
-
National Taiwan University HospitalCompletedLocally Advanced and Recurrent/Metastatic Gastric Cancer
-
Women's Hospital School Of Medicine Zhejiang UniversityAkesoNot yet recruitingCervical Cancer | Uterine Cervical Neoplasms | Cancer of Cervix | Uterine Cervical Cancer | Cervical Neoplasms | Cancer of the Uterine Cervix
-
Peking University Third HospitalNot yet recruitingCoronary Artery DiseaseChina
-
Sun Yat-sen UniversityNot yet recruitingCervical Cancer | Chemotherapy Effect | Neoadjuvant Therapy | Programmed Cell Death 1 Receptor / Antagonists & Inhibitors
-
Boston Scientific CorporationTerminatedBrain Neoplasms | Glioblastoma MultiformeUnited States
-
Beijing HospitalCompleted
-
Third Military Medical UniversityUnknown
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States